Accession Number: | 0001562180-21-003230 |
Date: | 2021-05-03 |
Issuer: | BLUEBIRD BIO, INC. (BLUE) |
Original Submission Date: |
COLE JASON
C/O BLUEBIRD BIO, INC.
60 BINNEY STREET
CAMBRIDGE, MA 02142
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2021-05-03 | S | 38 | d | $30.15 | 47,922 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|
ID | footnote |
---|---|
f1 | shares were sold to cover tax withholding obligations incurred in connection with the vesting of restricted stock units. |
f2 | the range in prices for the transaction reported on this line was $29.85 to $30.42. the average weighted price was $30.1511. the reporting person will provide, upon request by the sec, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |